OpenAI and Molecule. one show how a near-autonomous AI chemist using GPT-5.
Machine-generated by The Flow from the publisher's headline and feed description — not written or checked by a human. The full article lives at OpenAI Blog.
Connor Coley works at the interface of chemistry and machine learning, to discover and design new drug compounds.
The Perspective reviews the rapid growth of agentic AI systems in computational chemistry, noting an increase from a handful in 2024 to about fifty by August 2026. These systems are evolving from assisting with specific tasks to autonomously designing, executing, and analyzing in‑silico experiments, even drafting manuscripts. While fully autonomous AI scientists are not yet realized and human oversight remains, the trend toward commoditized generalist agents suggests a future where specialized systems may become obsolete, prompting reflection on the field’s direction and priorities.
OpenAI introduces a real-world evaluation framework to measure how AI can accelerate biological research in the wet lab. Using GPT-5 to optimize a molecular cloning protocol, the work explores both the promise and risks of AI-assisted experimentation.
arXiv:2608. 07454v1 Announce Type: cross Abstract: The total synthesis of a complex molecule is among the most demanding intellectual and experimental feats in chemistry: a chemist must plan many steps ahead for how to assemble simple building blocks into an intricate target, devise backup strategies, and anticipate procedural challenges.
OpenAI introduces the first research cases showing how GPT-5 accelerates scientific progress across math, physics, biology, and computer science. Explore how AI and researchers collaborate to generate proofs, uncover new insights, and reshape the pace of discovery.